"The AntiViral Research Center (AVRC) HQ develops and conducts innovative research that enhances the quality and duration of life for people living with or affected by HIV infection and other infections of global significance. The award-winning research center is an established leader in San Diego’s HIV research community and is well known for its HIV testing programs. Internationally, the AVRC extends its research and education programs to Africa, Asia, and South America."

During the past decade, Ucsd, Avrc Crs conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 39 clinical trials were completed, i.e. on average, 81.3% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 16 clinical trials were completed. i.e. 76.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ucsd, Avrc Crs" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 78 trials, followed by "AIDS Clinical Trials Group" with 21 trials sponsored, "University of California, San Diego" with 15 trials sponsored, "Gilead Sciences" with 4 trials sponsored and "Bristol-Myers Squibb" with 4 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ucsd, Avrc Crs" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 25 trials as a collaborator, "Gilead Sciences" with 7 trials as a collaborator, "AIDS Clinical Trials Group" with 6 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator and "Glaxo Wellcome" with 4 trials as a collaborator. Other collaborators include 50 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "Ucsd, Avrc Crs" are "HIV Infections" (76 trials), "HIV-1 Infection" (11 trials), "Hepatitis C" (10 trials), "HIV" (6 trials) and "HIV Infection" (4 trials). Many other conditions were trialed in "Ucsd, Avrc Crs" in a lesser frequency.

Most popular intervention types in "Ucsd, Avrc Crs" are "Drug" (98 trials), "Biological" (17 trials), "Other" (9 trials), "Device" (7 trials) and "Behavioral" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Zidovudine" (15 trials), "Lamivudine" (9 trials), "Stavudine" (9 trials) and "Didanosine" (8 trials). Other intervention names were less common.

The vast majority of trials in "Ucsd, Avrc Crs" are 123 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ucsd, Avrc Crs". undefined are not yet recruiting, 10 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 98 completed trials in Ucsd, Avrc Crs, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Ucsd, Avrc Crs, 14 "Phase 1" clinical trials were conducted, 54 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 18 trials that are defined as “Not Applicable".